1. Home
  2. REPL vs NX Comparison

REPL vs NX Comparison

Compare REPL & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$10.17

Market Cap

721.7M

Sector

Health Care

ML Signal

HOLD

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$16.45

Market Cap

599.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
REPL
NX
Founded
2015
1927
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
721.7M
599.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
REPL
NX
Price
$10.17
$16.45
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
1.7M
906.3K
Earning Date
11-06-2025
12-11-2025
Dividend Yield
N/A
1.94%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,837,641,000.00
Revenue This Year
N/A
$2.52
Revenue Next Year
N/A
$3.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.81
52 Week Low
$2.68
$11.04
52 Week High
$14.80
$29.67

Technical Indicators

Market Signals
Indicator
REPL
NX
Relative Strength Index (RSI) 61.36 76.88
Support Level $9.35 $13.18
Resistance Level $11.09 $14.11
Average True Range (ATR) 0.60 0.84
MACD -0.08 0.42
Stochastic Oscillator 53.32 55.16

Price Performance

Historical Comparison
REPL
NX

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: